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The purpose of this study is to determine if amino acid neurotransmitters such as gamma-aminobutyric acid
(GABA), taurine, glutamate (Glu), and aspartate (Asp) can scavenge activated carbonyl toxicants. In vitro, direct
reaction between malondialdehyde (MDA) and amino acids was researched using different analytical methods. The
results indicated that scavenging activated carbonyl function of taurine and GABA is very strong and that of Glu
and Asp is very weak in pathophysiological situations. The results provided perspective into the reaction
mechanism of taurine and GABA as targets of activated carbonyl such as MDA in protecting nerve terminals. In vivo,
we studied the effect of taurine and GABA as antioxidants by detecting MDA concentration and superoxide
dismutase (SOD) and glutathione peroxidase (GSH-Px) activities. It was shown that MDA concentration was
decreased significantly, and the activities of SOD and GSH-Px were increased significantly in the cerebral cortex and
hippocampus of acute epileptic state rats, after the administration of taurine and GABA. The results indicated that
the peripherally administered taurine and GABA can scavenge free radicals and protect the tissue against activated
carbonyl in vivo and in vitro.
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There is a common character for all neurodegenerative
diseases: all of which, such as Parkinson's disease (PD)
and Alzheimer's disease (AD), are connected with neu-
ronal apoptosis induced by oxidative stress and carbonyl
stress [1,2]. Oxidative injury plays a role in the initiation
and progression of epilepsy [3]. In pathophysiological sit-
uations of the brain, the high metabolic rate, low concen-
tration of glutathione and antioxidant enzyme catalase,
and high proportion of polyunsaturated fatty acids make
the brain tissue and DNA particularly susceptible to oxi-
dative and carbonyl damage causing neurodegenerative
disorders [4-6]. The Maillard reaction and advanced lipid* Correspondence: dy_dengyan@yahoo.com.cn; nyhejnn@yahoo.cn
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in any medium, provided the original work is pperoxidation reactions lead to the formation of advanced
glycation end products (AGEs) and advanced lipoxidation
end products (ALEs), whose processes have been widely
documented to be responsible for the formation of various
age pigment-like fluorophores and many chronic diseases,
such as neuronal degenerative diseases, chronic fatigue
syndrome, and physiological aging [7-11]. A variety of
reactive carbonyl intermediates derived from Maillard
and lipid peroxidation reactions acts as intermediates in
the formation of AGEs and ALEs [12,13]. These car-
bonyl compounds were found to react readily with an
amino group of proteins with the formation of protein
aggregates, resulting in protein structural and functional
alterations [14].
Malondialdehyde (MDA) is the well-studied intermedi-
ate of oxidative stress [15]. These reactive unsaturated car-
bonyls can target a variety of biological components, such
as structural and functional proteins and nucleic acids
[7,16]. MDA causes tissue injury and the depression of en-
ergy metabolism, thus representing biochemical markers
for disease progression and lipid peroxidation, such asOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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sclerosis (ALS) [18], AD, and vascular dementia [19,20].
Recent research results suggest that schizophrenic pa-
tients exhibit increased MDA levels, which lead to neu-
ronal damage [21]. ALEs such as MDA have been
implicated in the neuronal loss observed in a variety of
neuropathological cases including AD, ALS, PD, and
ischemia [2,16,22]. These findings further support a role
of carbonyl injury in the pathogenesis and the potential
benefits of antioxidant therapy [23].
Taurine (2-aminoethanesulfonic acid) and gamma-
aminobutyric acid (GABA) are both natural amino acids
with wide occurrence. In the context of the neural sys-
tem, taurine and GABA are inhibitory amino acid neuro-
transmitters, and glutamate and aspartate are excitatory
amino acids. Taurine was originally described to inhibit
lipid peroxidation [24]. At present, taurine has been
demonstrated to protect the brain against lipid peroxida-
tion and oxidative stress [25,26]. It has also been shown
that GABA exhibits anti-hypertensive effect, activates
the blood flow, and increases the oxygen supply in the
brain to enhance metabolic function of brain cells [27].
Evidence suggests GABA-improved visual cortical func-
tion in senescent monkeys [28]. Decreased proportion of
GABA associated with age-related degradation of neu-
ronal function and neuronal degenerative diseases [29].
Recent study showed GABA-alleviated oxidative damage
[30]. Glutamate (Glu) and aspartate (Asp) are reported
to prevent cardiac toxicity by alleviating oxidative stress
[31]. In this paper, it is hypothesized that several amino
acids may inhibit the formation of ALEs and scavenge
reactive carbonyl compounds such as MDA based on a
potential carbonyl-amine reaction under physiological
conditions, and its function is in vitro compared; also,
the strong inhibition function of amino acids was inves-
tigated in vivo.Methods
Materials and preparation
Taurine, GABA, Glu, and Asp were purchased from
Sinopharm Chemical Reagent C., Ltd (Shanghai, China).
1,1,3,3-Tetramethoxypropane (TMP) and pentylenetetra-
zol (PTZ) were obtained from Fluka Chemie AG (Buchs,
Switzerland). MDA detection kit, superoxide dismutase
(SOD) detection kit, glutathione peroxidase (GSH-Px) de-
tection kit, and total protein quantification kit (Coomassie
Brilliant Blue) were purchased from Nanjing Jiancheng
Bioengineering Institute (Nanjing, China). Other chemi-
cals used were purchased from HuiHong Chemical Re-
agent C., Ltd. (Changsha, China).
MDA stock solution (40 mM) was prepared by hydro-
lyzing TMP according to a method described by Kikugawa
and Beppu [32]. Thus, 0.17 mL (1.0 mmol) of TMP wasadded in 4 mL of 1.0 M HCl and shaken at 40°C for about
2 min. After the TMP was fully hydrolyzed, the pH was
adjusted to 7.4 with 6.0 M NaOH, and the stock solution
was finally made up to 25 mL with 0.2 M PBS (pH 7.4).
The stock solution was checked by measuring the absor-
bance at 266 nm using ε266 = 31,500 M
−1 cm−1.In vitro incubation experiments and HPLC, fluorescence,
and LC/MS analysis of the incubation mixture
Several amino acids were incubated with MDA (5.0 mM)
in 5 mL of 0.2 M PBS at 37°C (pH 7.4). Samples were
analyzed by high-performance liquid chromatography
(HPLC), fluorescence, or liquid chromatography/mass
spectrometry (LC/MS) [26,33].Animals and drug treatment
Male or female Sprague–Dawley rats (180 to 230 g) were
employed for the experiments (Shanghai Experimental
Animal Center, Chinese Academy of Sciences). Five rats
were kept in individual cages with water and food avail-
able ad libitum. The animal room was maintained at 21°C
to 23°C, with a 12-h light–dark cycle. All experimental
procedures were approved by the Committee of Labora-
tory Animals, Chinese Academy of Sciences.
Rats were intraperitoneally (i.p.) administered with
70-mg/kg dose of 1% PTZ (dissolved in saline) to induced
auditory evoked potential (AEP). Control animals received
the same amount of saline injections. The seizures were
rated according to the following criteria [34,35]: stage 0,
no response; stage I, ear and facial twitching; stage II,
myoclonic jerks without upright position; stage III, myo-
clonic jerks, upright position with bilateral forelimb clo-
nus; stage IV, clonic-tonic seizure; and stage V, generalized
clonic-tonic seizures, loss of postural control.
Experimental rats were divided into four groups as fol-
lows: group 1, rats were treated with saline; group 2, rats
were i.p. injected with a dose of 70 mg/kg PTZ to induce
the onset of seizures; group 3, rats were i.p. co-
administered with a dose of 70 mg/kg PTZ since i.p.
injected with a dose of 500 mg/kg taurine after 30 min;
and group 4, rats were i.p. co-administered with a dose
of 70 mg/kg PTZ since i.p. injected with a dose of
500 mg/kg GABA after 30 min. After 1 h, the animals
were killed, the brains were dissected, the cerebral cortex
and hippocampus tissues were removed, and blood was
withdrawn. The brain tissue was rinsed in ice-cold normal
saline, added to nine times ice-cold normal saline, homog-
enized, and centrifuged at 5,000×g for 15 min at 4°C. The
blood was centrifuged at 3,000×g for 15 min. The super-
natant and serum were obtained and stored in a −20°C re-
frigerator for MDA assays and antioxidant enzymes'
(SOD, GSH-Px) activity assays. The protein concentration
was determined by Coomassie Brilliant Blue method.
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The MDA and antioxidant enzymes' (SOD, GSH-Px) ac-
tivity of the cerebral cortex and the hippocampus tissue
and blood from PTZ-induced AEP were evaluated by
MDA assay and antioxidant enzymes' (SOD, GSH-Px)
kits according to the manufacturer's instructions.
Statistics
Data were shown as mean ± S.E.M. Statistical evaluation
was carried out by one-way analysis of variance (ANOVA)
followed by Scheffe's multiple range tests. P < 0.05 was
considered to be significant.Figure 1 Principal reaction products. Taurine + MDA, GABA + MDA, Glu
Glu, and Asp (5.0 mM) were incubated with MDA (5.0 mM) in 0.2 mM PBS (pH
separated by HPLC analysis were observed at 278 (A) and 391 nm (B). The pri
were observed at 278 (C) and 391 nm (D). The principal reaction products of
278 (E) and 278 nm (F).Results
Incubation products assayed by HPLC and fluorescence
The mixture was separated at acidic pH through HPLC
and fluorescence after amino acids (5.0 mM) were incu-
bated with MDA (5.0 mM) in 0.2 M PBS, pH 7.4, at 37°C
for 48 h. Because the standard absorbance spectrum of
MDA showed a peak at 266 nm under a neutral condition
and a peak at 245 nm under an acidic condition while
taurine had no absorption in the range of 200 to 400 nm,
products should show a peak at approximately 245 nm.
By choosing the wavelengths at 274 to 278 nm, the first
new products (products 1, 3, 5, and 6) were observed+ MDA, and Asp + MDA separated by HPLC analysis. Taurine, GABA,
7.4) at 37°C for 24 h. The principal reaction products of taurine + MDA
ncipal reaction products of GABA + MDA separated by HPLC analysis
Glu + MDA and Asp + MDA separated by HPLC analysis were observed at











Product 1 278 No
Product 2 236, 263, 391 392/456
Product 3 274 No
Product 4 231, 262, 394 395/458
Product 5 276 No
Product 6 276 No
Values of the starting materials and products observed by incubation of
taurine + MDA, GABA + MDA, Glu + MDA, and Asp + MDA for 48 h.
Figure 2 LC/MS analysis. Principal reaction products of taurine + MDA, G
and (B) were the mass spectra of principal reaction products of taurine+MD
(F) was that of Asp + MDA.
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min (Figure 1C), 3.705 min (Figure 1E), and 7.152 min
(Figure 1F). The second new products (products 2 and 4)
displayed simultaneous ultraviolet absorbance at 231 to
236 nm, 262 to 263 nm, and 391 to 394 nm with the re-
tention time of 12.351 min (Figure 1B) and 8.519 min
(Figure 1D). The first new product did not show any
fluorescence, while the second new product showed a
stable lipofuscin-like blue (excitation wavelength (Ex) 392
to 395 nm/emission wavelength (Em) 456 to 460 nm)
fluorescence. The UV absorption maxima and fluores-
cence Ex/Em values of MDA, amino acids, and different
products are shown in Table 1. These observations sug-
gest that taurine or GABA reacts rapidly with MDA; in
comparison, the reaction of Glu or Asp with MDA is dif-
ficult under supraphysiological conditions.ABA + MDA, Glu + MDA, and Asp + MDA after incubating for 48 h. (A)
A; (C) and (D) were those of GABA+MDA; (E) was that of Glu +MDA;
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The reaction products were identified using LC/MS after
the mixtures of amino acids and MDA were incubated
for about 48 h. The mixture of taurine + MDA was ana-
lyzed that a total ion current chromatogram in compari-
son with a DAD chromatogram and the mass spectrum
corresponding to the retention time of product 1 was m/z
180.0 [MP1 + H]
+ (Figure 2A). Similarly, the mass spec-
trum corresponding to product 2 was m/z 260.0 [MP2 +
H]+ (Figure 2B). After the mixture of GABA and MDA
was incubated, the mass spectrum corresponding to the
retention time of product 3 was m/z 158.2 [MP3 + H]
+
(Figure 2C). Similarly, the mass spectrum corresponding
to product 4 was m/z 238.2 [MP4 + H]
+ (Figure 2D). The
mixture of Glu + MDA and Asp + MDA was analyzed.
The mass spectrum corresponding to the retention time
of product 5 was m/z 202.0 [MP5 + H]
+ (Figure 2E) and
that of product 6 was m/z 187.0 [MP6 + H]
+ (Figure 2F).
The molecular structures of different products can be
illustrated in Figure 3 according to the molecular
weight and the knowledge in the related research field
[7,13,31,36,37]. The formation mechanism of products 2
and 4 was similar to that of the other fluorescent
dihydropyridine derivatives, which are clearly elaborated


















Figure 3 Proposed structures. Taurine + MDA, GABA + MDA, Glu + MDA
positions during the product formation.Comparison of the formation of reaction products of
taurine, GABA, Glu, or Asp with MDA
By comparison, the fast formation of products shows
that taurine can react rapidly with MDA; the reaction
activity of GABA with MDA is slightly weak, but those
of Glu and Asp are very slow. The relativistic mass of
the nonfluorescent product after reacting between tau-
rine and MDA is 10 times as great as that of the reaction
between Glu and MDA and 40 times as great as that be-
tween Asp and MDA. Between GABA and MDA, the
relativistic mass is 4 times as great as that between Glu
and MDA and 14 times as great as that between Asp
and MDA (Figure 4). The relativistic mass of the fluores-
cent products after reacting between taurine and MDA
is three times than that of the reaction between GABA
and MDA in 24 h (Figure 5).
Content of MDA in PTZ-induced acute epileptic state rats
In the hippocampus of rat brains, the highest content of
MDA is in AEP + normal saline (NS) group and lowest in
the control + NS group. When AEP groups are treated
using taurine or GABA, the MDA concentration of the
taurine + AEP and GABA + AEP groups is reduced in
comparison with that of the AEP + NS. The level of MDA
of the AEP + NS group displays significant difference (P <


















, and Asp + MDA reaction products. Dotted lines indicate bonding




























 Product of taurine + MDA
 Product of GABA + MDA
 Product of Glu + MDA
 Product of Asp + MDA
Figure 4 Comparison of the formation of nonfluorescent
products. Expressed as peak area, based on the UV absorption
maxima of the nonfluorescent product, during the reaction of
taurine, GABA, Glu (Glu), or Asp (Asp) with MDA. Taurine, GABA, Glu
(Glu), or Asp (Asp) (5.0 mM) was incubated with MDA (5.0 mM) in
0.2 mM PBS (pH 7.4) at 37°C for 24 h.
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AEP group. MDA concentrations among the taurine +
AEP, GABA + AEP, and control + NS groups have no stat-
istical significance. In the rat cerebral cortex, the highest
content of MDA is in the acute epileptic state (AEP) +
NS group. MDA concentrations of the taurine + AEP,
GABA + AEP, and control + NS groups are very close to
each another. When AEP groups are treated using taurine


























Figure 5 Comparison of the formation of the fluorescent products du
area and fluorescence intensity, based on the UV absorption maxima of the fl
formation of the fluorescent products. Taurine or GABA (5.0 mM) was incubat
absorbance of the fluorescent product of (■) taurine, (●) GABA, (▲) Glu, or (▼
fluorescent product of (□) taurine, (○) GABA, (△) Glu, or (▽) Asp with MDA wassignificant difference (P < 0.05) relative to those of the
GABA + AEP and taurine + AEP groups. MDA concen-
trations among the taurine + AEP, GABA + AEP, and con-
trol + NS groups have no statistical significance. In the rat
serums, the highest content of MDA is in the AEP + NS
group. However, the MDA concentration among the tau-
rine + AEP, GABA + AEP, and control + NS groups has
no statistical significance. MDA concentrations of differ-
ent groups are shown in Table 2.
Activities of SOD and GSH-Px in PTZ-induced acute
epileptic state rats
In the hippocampus of rat brains, the activity of SOD is
lowest for the AEP + NS group and highest for the con-
trol + NS group. When AEP groups are treated using
taurine or GABA, SOD activities of the taurine + AEP
and GABA + AEP groups are heightened more than that
of the AEP + NS group. SOD activity of the AEP + NS
group has significant difference (P < 0.05) relative to that
of the GABA + AEP and taurine + AEP group, but those
among the taurine + AEP, GABA + AEP, and control +
NS groups have no statistical significance. In the cere-
bral cortex of the rats, the activity of SOD is lowest in
the AEP + NS group and slightly high in the control +
NS group. When AEP groups are treated using taurine
or GABA, the SOD activities of the taurine + AEP and
GABA + AEP groups are heightened more than that of
the control + NS, but those among the taurine + AEP,
GABA + AEP, and control + NS groups have no statis-
tical significance. SOD activities of different groups are






















ring the reaction of taurine or GABA with MDA. Expressed as peak
uorescent product, and fluorescence yield corresponding to the
ed with MDA (5.0 mM) in 0.2 mM PBS (pH 7.4) at 37°C for 24 h. UV
) Asp with MDA was measured at 391 nm. Fluorescence yield of the
measured at Ex 392 nm/Em 456 nm. Data are mean ± S.D. of triplicates.
Table 4 Test result of GSH-Px activity of the hippocampus





Control + NS 26.21 ± 1.30* 32.14 ± 10.97*
AEP + NS 14.55 ± 2.07 13.90 ± 2.52
Taurine + AEP 28.17 ± 3.11* 36.68 ± 12.90*
GABA + AEP 26.12 ± 2.97* 37.65 ± 8.47*
Data were shown as mean ± S.E.M. Statistical evaluation was carried out by
one-way analysis of variance (ANOVA) followed by Scheffe's multiple range
tests: *P < 0.05, AEP + NS versus control + NS, taurine + AEP, or GABA + AEP.
Table 2 Test result of MDA content of the hippocampus,







Control + NS 14.20 ± 4.54* 14.87 ± 2.64* 10.00 ± 5.19
AEP + NS 23.98 ± 4.90 25.40 ± 3.37 13.00 ± 1.92
Taurine + AEP 18.46 ± 2.27 14.55 ± 3.61* 9.55 ± 2.04
GABA + AEP 17.45 ± 1.81* 15.72 ± 7.38* 10.12 ± 2.12
Data were shown as mean ± S.E.M. Statistical evaluation was carried out by
one-way analysis of variance (ANOVA) followed by Scheffe's multiple range
tests: *P < 0.05, AEP + NS versus control + NS, taurine + AEP, or GABA + AEP.
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the activity of GSH-Px is lowest in the AEP + NS group
and close to each other in the taurine + AEP, GABA +
AEP, and control + NS groups. When AEP groups are
treated using taurine or GABA, the GSH-Px activity of the
AEP + NS group shows significant difference (P < 0.05)
relative to those of the GABA + AEP and taurine + AEP
groups, but those among the taurine + AEP, GABA +
AEP, and control + NS groups have no statistical signifi-
cance. GSH-Px activities of different groups are shown in
Table 4.
Discussion
Taurine is widely applied as an antioxidant or dietary
supplement and is demonstrated to reduce significantly
MDA levels in the serum and/or tissue [38]. GABA is
widely applied as an additive [26]. Similarly, it is reported
that Glu and Asp can prevent cardiac toxicity by alleviat-
ing oxidative stress [30].
Our results demonstrate that taurine or GABA reacts
rapidly with MDA, and the reaction of Glu or Asp with
MDA under supraphysiological conditions is difficult
(Figures 1 and 2). The observations are consistent with
the hypothesis that amino acids act as a sacrificial nucleo-
phile, trapping reactive intermediates [36,37]. Scavenging
carbonyl function of four amino acids is shown in Figures 4
and 5. The strong inhibition effect of taurine and GABA
on MDA and the fast formation of products show that
taurine and GABA can react rapidly; however, the reaction
of Glu or Asp with MDA is very weak underTable 3 Test result of SOD activity of the hippocampus





Control + NS 24.27 ± 1.83* 18.22 ± 0.31
AEP + NS 20.14 ± 0.56 16.68 ± 1.96
Taurine + AEP 23.86 ± 1.73* 22.49 ± 2.09
GABA + AEP 23.16 ± 1.38* 21.97 ± 4.93
Data were shown as mean ± S.E.M. Statistical evaluation was carried out by
one-way analysis of variance (ANOVA) followed by Scheffe's multiple range
tests: *P < 0.05, AEP + NS versus control + NS, taurine + AEP, or GABA + AEP.supraphysiological conditions due to its different chemical
structures (Table 1, Figure 3). In addition, if it is thought
of four amino acids in the context of the neural system,
taurine and GABA are important inhibitory amino acid
neurotransmitters, and Glu and Asp are significant excita-
tory amino acid neurotransmitters. Glu and Asp uptake
induce excitotoxicity, thereby causing oxidative stress and
further lipid peroxidation [6]. MDA-related carbonyl stress
injures neurons by triggering Ca2+ influx and calcium
overload [39]. Indeed, it is possible that only taurine and
GABA prevent neurons from damage with anti-
carbonylation toxic function besides inhibiting neuron
superexcitation [40]. Also, studies [41] thought GABA
treatment could prolong survival of transplanted β cells.
MDA was considered to suppress cerebral function by
breaking homeostasis between the excitation and inhib-
ition [42]. However, MDA content in the brain tissue is
enhanced dramatically to as high as 10 to 30 μm under
pathophysiological conditions [43], such as aging and neu-
rodegenerative diseases [44,45]. Thus, in vivo system, these
results are considered if taurine and GABA can scavenge
active carbonyl besides MDA in neural tissues or cells
such as the epileptic focus [3] accumulated chemicals on
their membrane. Here, taking AEP for example, the
neuroprotective effects of taurine and GABA are investi-
gated on peroxidation of the AEP model.
Our results have shown that MDA concentration was
elevated and SOD activity decreased in the AEP rats.
After administration of taurine and GABA in the cere-
bral cortex and hippocampus of AEP rats, the level of
MDA was decreased significantly (Table 2), and the ac-
tivities of SOD and GSH-Px were increased significantly.
However, two administration groups had no statistical
difference from each other as well as with the normal
group (Tables 3 and 4). The result indicated that the per-
ipherally administered taurine and GABA can scavenge
free radicals and protect the tissue against active car-
bonyl harm.
Conclusions
Our study in vitro demonstrates that four amino acid
neurotransmitters inhibit the formation of reactive
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with MDA to form different conjugated complexes.
These data illustrate taurine's or GABA's strong function
to scavenge endogenous and/or further extrinsic unsat-
urated reactive carbonyls. In comparison, the scavenging
function of Glu or Asp is very weak when reacting with
MDA. The molecular mechanism of taurine's or GABA's
inhibition and the investigation of its neuroprotective ef-
fects in vivo may prove useful for limiting the increased
chemical modification of tissue proteins and cells on
oxidative stress.
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